Sign In
Buy LIVN
$71.33
-2.00 (-2.73%)
At Close: Jun 03, 2026
Global Neurostimulation Devices Market Report 2020 - Major Players are Medtronic, Cyberonics, Boston Scientific, St. Jude Medical, and Nevro
10:58am, Wednesday, 04'th Mar 2020
Dublin, March 04, 2020 -- The "Neurostimulation Devices Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.The global.
LivaNova (NASDAQ:LIVN) Rating Lowered to Sell at Zacks Investment Research
07:04am, Wednesday, 04'th Mar 2020
LivaNova (NASDAQ:LIVN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports.
Piper Sandler Equities Analysts Reduce Earnings Estimates for LivaNova PLC (NASDAQ:LIVN)
07:44am, Monday, 02'nd Mar 2020
LivaNova PLC (NASDAQ:LIVN) – Analysts at Piper Sandler lowered their Q2 2020 EPS estimates for LivaNova in a note issued to investors on Wednesday, February 26th. Piper Sandler analyst M. O’brien
Jefferies Financial Group Weighs in on LivaNova PLC's Q1 2020 Earnings (NASDAQ:LIVN)
06:44am, Monday, 02'nd Mar 2020
LivaNova PLC (NASDAQ:LIVN) – Jefferies Financial Group lowered their Q1 2020 earnings per share estimates for LivaNova in a research report issued on Wednesday, February 26th. Jefferies Financial Gr
LivaNova (NASDAQ:LIVN) Upgraded to Buy by ValuEngine
07:54am, Saturday, 29'th Feb 2020
LivaNova (NASDAQ:LIVN) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, ValuEngine reports. Several other brokerag
Pune, Feb. 28, 2020 -- Vagus Nerve Stimulation (VNS) Market Overview The global vagus nerve stimulation (VNS) market size is anticipated to reach USD 1,194.4 million by.
NEW YORK, Feb. 27, 2020 -- The global medical bionics market was valued at USD 20.3 billion in 2019 and is expected to grow at a CAGR of 8.0% during the forecast period..
LivaNova (LIVN) Receives a Rating Update from a Top Analyst
11:43am, Thursday, 27'th Feb 2020
Canaccord Genuity analyst Jason Mills maintained a Hold rating on LivaNova (LIVN) today and set a price target of $66.00. The company's shares closed last
LivaNova (LIVN) Receives a Rating Update from a Top Analyst
11:43am, Thursday, 27'th Feb 2020
Canaccord Genuity analyst
Jason Mills
maintained a
Hold
rating on LivaNova (
LIVN
–
Research Report
) today and set a price target of
$66.00
. The company’s shares closed last Monday at $62.70, cl
LivaNova (LIVN) Gets a Buy Rating from Berenberg Bank
09:21am, Thursday, 27'th Feb 2020
Berenberg Bank analyst Scott Bardo maintained a Buy rating on LivaNova (LIVN) yesterday and set a price target of $114.00. The company's shares closed
LivaNova (LIVN) Gets a Buy Rating from Berenberg Bank
09:20am, Thursday, 27'th Feb 2020
Berenberg Bank analyst
Scott Bardo
maintained a
Buy
rating on LivaNova (
LIVN
–
Research Report
) yesterday and set a price target of
$114.00
. The company’s shares closed last Monday at $62.70, c
LivaNova PLC (LIVN) Q4 2019 Earnings Call Transcript
02:33am, Thursday, 27'th Feb 2020
LIVN earnings call for the period ending December 31, 2019.
Edited Transcript of LIVN.L earnings conference call or presentation 26-Feb-20 1:00pm GMT
09:45pm, Wednesday, 26'th Feb 2020
Q4 2019 LivaNova PLC Earnings Call
LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression
09:44pm, Wednesday, 26'th Feb 2020
LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within its RECOVER clinical study.
LivaNova PLC (LIVN) CEO Damien McDonald on Q4 2019 Results - Earnings Call Transcript
06:17pm, Wednesday, 26'th Feb 2020
LivaNova PLC (NASDAQ:LIVN) Q4 2019 Earnings Conference Call February 26, 2020 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate
